AU5015296A - Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation - Google Patents

Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation

Info

Publication number
AU5015296A
AU5015296A AU50152/96A AU5015296A AU5015296A AU 5015296 A AU5015296 A AU 5015296A AU 50152/96 A AU50152/96 A AU 50152/96A AU 5015296 A AU5015296 A AU 5015296A AU 5015296 A AU5015296 A AU 5015296A
Authority
AU
Australia
Prior art keywords
aqueous solution
solution formulation
hydrochloride aqueous
procaterol hydrochloride
package holding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50152/96A
Inventor
Shinichi Ishikawa
Yuzo Kimura
Takakuni Matsuda
Masafumi Toda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU5015296A publication Critical patent/AU5015296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AU50152/96A 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation Abandoned AU5015296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-78564 1995-04-04
JP7856495 1995-04-04
PCT/JP1996/000772 WO1996031195A1 (en) 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation

Publications (1)

Publication Number Publication Date
AU5015296A true AU5015296A (en) 1996-10-23

Family

ID=13665401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50152/96A Abandoned AU5015296A (en) 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation

Country Status (7)

Country Link
EP (1) EP0820274A1 (en)
KR (1) KR19980703582A (en)
AR (1) AR002981A1 (en)
AU (1) AU5015296A (en)
CA (1) CA2217360A1 (en)
MX (1) MX9707695A (en)
WO (1) WO1996031195A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002245134A1 (en) * 2000-12-21 2002-08-06 Alcon Universal Ltd. Artificial tear composition adapted to be used with contact lenses
US9636355B2 (en) 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
PT3139903T (en) * 2014-05-07 2019-10-24 Croma Pharma Ges M B H Aqueous ophthalmic solution and method for treating dry eye syndrome
KR102487614B1 (en) * 2015-10-06 2023-01-12 에이치엘비테라퓨틱스 주식회사 Preparation of an ophthalmic composition comprising thymosin beta 4
RU2743274C9 (en) * 2015-11-10 2021-04-08 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Pharmaceutical preparation for treatment of arthrological diseases
RU2612019C1 (en) * 2015-12-11 2017-03-01 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Production method of preparation injectable form based on sulfate chondroitin
CN114159398B (en) * 2021-03-22 2023-05-23 南京艾德加生物制药科技有限公司 Procaterol hydrochloride oral solid composition and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2638156B2 (en) * 1988-11-11 1997-08-06 優樹 小田切 Pharmaceutical composition
JP3390477B2 (en) * 1993-01-25 2003-03-24 生化学工業株式会社 Pharmaceutical composition and method for producing the same

Also Published As

Publication number Publication date
AR002981A1 (en) 1998-05-27
KR19980703582A (en) 1998-11-05
EP0820274A1 (en) 1998-01-28
CA2217360A1 (en) 1996-10-10
MX9707695A (en) 1997-12-31
WO1996031195A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
AU699581B2 (en) Glycinamide derivatives, processes for their preparation and medicines containing them
HUP9901331A3 (en) Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, and pharmaceutical compositions containing said salts
AU2015499A (en) Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
AU7214796A (en) Novel amino acid derivatives, their preparation and use
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
AU7306096A (en) Aryl-piperazine cyclic amine derivatives, preparation thereof and pharmaceutical compositions containing same
ZA96960B (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
AU5015296A (en) Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
HK1014938A1 (en) Oxazolidinone derivatives, their preparation and therapeutical use
AU681204B2 (en) N-substituted azabicycloalkane derivatives, their preparation and use
AU1407197A (en) Stable vancomycin hydrochloride solutions
AU2593092A (en) Condoms, packages and unwinding aid for condoms
HK1010868A1 (en) Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
AU4633796A (en) Benzoxazepine derivatives, salts thereof, and drugs containing the same
AU1251295A (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use
IL136230A0 (en) An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
AU4318397A (en) Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
HUP0002821A3 (en) Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
AU6473699A (en) Aqueous drug formulation for oral application
EP0758676A3 (en) Aqueous film-forming solutions based on metal-phosphate and amine, and their use
AU5065400A (en) Film, especially for packaging purposes, and packaging
AU6934396A (en) 1-phenyl-3-4-{benzylpiperidinyl-1}-propanol-1 derivatives, preparation thereof and therapeutical application thereof

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted